Ratiometric electrochemical OR gate assay for NSCLC-derived exosomes

Abstract

Non-small cell lung cancer (NSCLC) is the most common pathological type of LC and ranks as the leading cause of cancer deaths. Circulating exosomes have emerged as a valuable biomarker for the diagnosis of NSCLC, while the performance of current electrochemical assays for exosome detection is constrained by unsatisfactory sensitivity and specificity. Here we integrated a ratiometric biosensor with an OR logic gate to form an assay for surface protein profiling of exosomes from clinical serum samples. By using the specific aptamers for recognition of clinically validated biomarkers (EpCAM and CEA), the assay enabled ultrasensitive detection of trace levels of NSCLC-derived exosomes in complex serum samples (15.1 particles μL−1 within a linear range of 102–108 particles μL−1). The assay outperformed the analysis of six serum biomarkers for the accurate diagnosis, staging, and prognosis of NSCLC, displaying a diagnostic sensitivity of 93.3% even at an early stage (Stage I). The assay provides an advanced tool for exosome quantification and facilitates exosome-based liquid biopsies for cancer management in clinics. Graphical Abstract

Comprehensive Metabolic Fingerprints Characterize Neuromyelitis Optica Spectrum Disorder by Nanoparticle-Enhanced Laser Desorption/Ionization Mass Spectrometry

“…48 Furthermore, the NPELDI MS featured desirable detection duration (on the scale of seconds), trace biofluid consumption (at least 500 nL), and an affordable price ($3/test). To date, the studies generally focus on the targeted quantitation of specific metabolites, 49,50 hardly collecting comprehensive fingerprint information. By harnessing the desirable detection duration, biofluid consumption, and data stability, the NPELDI MS has adequate reliability in comprehensive metabolic profiling and biomarker discovery in the next stage.…”

Troponin T1 in tumorigenesis and immune modulation: Insights into multiple cancers and kidney renal clear cell carcinoma

“…An imminent imperative exists to unearth innovative biological insights and prognostic/predictive markers that can adeptly facilitate precision‐based management for individuals grappling with cancer 18,19 . The intracellular signalling pathways governing cancer initiation and progression are highly complex, involving dysregulated expression of various structural and regulatory proteins 20–22 . Elucidating the participation of unexpected proteins, such as TNNT1, in oncogenesis could foster a deeper understanding of tumour biology and facilitate the discovery of novel therapeutic targets.…”

“…18,19 The intracellular signalling pathways governing cancer initiation and progression are highly complex, involving dysregulated expression of various structural and regulatory proteins. [20][21][22] Elucidating the participation of unexpected proteins, such as TNNT1, in oncogenesis could foster a deeper understanding of tumour biology and facilitate the discovery of novel therapeutic targets. Tumour immunotherapy has revolutionized cancer treatment by leveraging the immune system's ability to combat malignancies.…”

A Label-Free and Antibody-Free Molecularly Imprinted Polymer-Based Impedimetric Sensor for NSCLC-Cells-Derived Exosomes Detection

“…Lung cancer is currently regarded as the leading cause of cancer-related death worldwide. As NSCLC accounts for about 80% of cases and shows a 5-year survival rate as low as 10–15% [ 1 , 2 ], early diagnosis plays an important role in improving the prognosis and survival [ 3 ].…”